256 related articles for article (PubMed ID: 30798159)
1. Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo.
Cao Y; Feng YH; Gao LW; Li XY; Jin QX; Wang YY; Xu YY; Jin F; Lu SL; Wei MJ
Int Immunopharmacol; 2019 May; 70():110-116. PubMed ID: 30798159
[TBL] [Abstract][Full Text] [Related]
2. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D aggravates breast cancer by inducing immunosuppression in the tumor bearing mouse.
Cao Y; Du Y; Liu F; Feng Y; Cheng S; Guan S; Wang Y; Li X; Li B; Jin F; Lu S; Wei M
Immunotherapy; 2018 Jun; 10(7):555-566. PubMed ID: 29852828
[TBL] [Abstract][Full Text] [Related]
4. SMAR1 promotes immune escape of Tri-negative Breast Cancer through a mechanism involving T-bet/PD-1 Axis.
Xiaohua W; Hongxia X; Rong D; Pingping W; Xing H; Yichao Z; Cheng C
Cell Mol Biol (Noisy-le-grand); 2018 Sep; 64(12):70-75. PubMed ID: 30301506
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma inhibits aldehyde dehydrogenasebright cancer stem cells in the 4T1 mouse model of breast cancer.
Zhuang X; Shi G; Hu X; Wang H; Sun W; Wu Y
Chin Med J (Engl); 2021 Dec; 135(2):194-204. PubMed ID: 34890380
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
7. L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo.
Cao Y; Feng Y; Zhang Y; Zhu X; Jin F
BMC Cancer; 2016 Jun; 16():343. PubMed ID: 27246354
[TBL] [Abstract][Full Text] [Related]
8. Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice.
Shu C; Sun P; Xie H; Huang W; Qi J; Ma Y
Int J Nanomedicine; 2020; 15():1983-1996. PubMed ID: 32308382
[TBL] [Abstract][Full Text] [Related]
9. A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T cells in murine breast cancer model.
Langroudi L; Hassan ZM; Ebtekar M; Mahdavi M; Pakravan N; Noori S
Int Immunopharmacol; 2010 Sep; 10(9):1055-61. PubMed ID: 20601187
[TBL] [Abstract][Full Text] [Related]
10. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
11. Arteether exerts antitumor activity and reduces CD4+CD25+FOXP3+ T-reg cells in vivo.
Azimi Mohamadabadi M; Hassan ZM; Zavaran Hosseini A; Gholamzad M; Noori S; Mahdavi M; Maroof H
Iran J Immunol; 2013 Sep; 10(3):139-49. PubMed ID: 24076591
[TBL] [Abstract][Full Text] [Related]
12. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
Li J; Wang S; Wang N; Zheng Y; Yang B; Wang X; Zhang J; Pan B; Wang Z
Cell Commun Signal; 2021 Aug; 19(1):89. PubMed ID: 34461944
[TBL] [Abstract][Full Text] [Related]
13. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.
Sahraei M; Bose M; Sanders JA; De C; DasRoy L; Nath S; Brouwer CR; Mukherjee P
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070449
[TBL] [Abstract][Full Text] [Related]
14. Reduced infiltration of regulatory T cells in tumours from mice fed daily with gamma-tocotrienol supplementation.
Subramaniam S; Anandha Rao JS; Ramdas P; Ng MH; Kannan Kutty M; Selvaduray KR; Radhakrishnan AK
Clin Exp Immunol; 2021 Nov; 206(2):161-172. PubMed ID: 34331768
[TBL] [Abstract][Full Text] [Related]
15. Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model.
Balog JÁ; Hackler L; Kovács AK; Neuperger P; Alföldi R; Nagy LI; Puskás LG; Szebeni GJ
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881770
[TBL] [Abstract][Full Text] [Related]
16. IL-7 inhibits tumor growth by promoting T cell-mediated antitumor immunity in Meth A model.
Tang JC; Shen GB; Wang SM; Wan YS; Wei YQ
Immunol Lett; 2014; 158(1-2):159-66. PubMed ID: 24406503
[TBL] [Abstract][Full Text] [Related]
17. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.
Jarnicki AG; Lysaght J; Todryk S; Mills KH
J Immunol; 2006 Jul; 177(2):896-904. PubMed ID: 16818744
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Dendritic Cell Vaccination in Experimental Breast Cancer Controls Immunity and Hepatic Metastases.
Vieira JF; Peixoto AP; Murta EFC; Michelin MA
Anticancer Res; 2021 Jul; 41(7):3419-3427. PubMed ID: 34230137
[TBL] [Abstract][Full Text] [Related]
19. Expression of a soluble TGF-beta receptor by tumor cells enhances dendritic cell/tumor fusion vaccine efficacy.
Zhang M; Berndt BE; Chen JJ; Kao JY
J Immunol; 2008 Sep; 181(5):3690-7. PubMed ID: 18714045
[TBL] [Abstract][Full Text] [Related]
20. CD4
Kindlund B; Sjöling Å; Yakkala C; Adamsson J; Janzon A; Hansson LE; Hermansson M; Janson P; Winqvist O; Lundin SB
Gastric Cancer; 2017 Jan; 20(1):116-125. PubMed ID: 26782287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
